|
Volumn 38, Issue 1, 2010, Pages 2-3
|
Allotransplantation or autotransplantation to the face, which first?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
ALLOGRAFT;
ALLOTRANSPLANTATION;
AUTOTRANSPLANTATION;
CANCER STAGING;
CANCER SURVIVAL;
CAROTID ARTERY;
EYELID;
FACE BURN;
FACE SURGERY;
FACIAL TRANSPLANTATION;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
JUGULAR VEIN;
KIDNEY TRANSPLANTATION;
LETTER;
LIVER TRANSPLANTATION;
LUNG TRANSPLANTATION;
MOUTH CARCINOMA;
PATIENT COMPLIANCE;
PHRENIC NERVE;
PLASMAPHERESIS;
QUALITY OF LIFE;
SKIN BIOPSY;
SKIN FLAP;
SURGICAL RISK;
VASCULAR DISEASE;
VASCULARIZATION;
DECISION MAKING;
FACIAL TRANSPLANTATION;
GRAFT REJECTION;
HAND;
HUMANS;
RECONSTRUCTIVE SURGICAL PROCEDURES;
TRANSPLANTATION, AUTOLOGOUS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT FAILURE;
|
EID: 74449090313
PISSN: 10105182
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcms.2009.10.026 Document Type: Letter |
Times cited : (3)
|
References (9)
|